Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Saima Usman, Naushin Waseem, Thuan Khanh Ngoc Nguyen, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4985-4985
Open Access | Times Cited: 265
Molecular targeted therapy for anticancer treatment
Hye‐Young Min, Ho‐Young Lee
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1670-1694
Open Access | Times Cited: 247
The Role of EREG/EGFR Pathway in Tumor Progression
Wanli Cheng, Po‐Hao Feng, Kang‐Yun Lee, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12828-12828
Open Access | Times Cited: 136
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 94
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 976-976
Open Access | Times Cited: 91
Drug-Tolerant Persister Cells in Cancer Therapy Resistance
Pavan Kumar Dhanyamraju, Todd D. Schell, Shantu Amin, et al.
Cancer Research (2022) Vol. 82, Iss. 14, pp. 2503-2514
Open Access | Times Cited: 71
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Zhe Zhang, Siyuan Qin, Yan Chen, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 69
Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review
Josef Yayan, Karl-Josef Franke, Melanie Berger, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 27
Programmable intratumoral drug delivery to breast cancer using wireless bioelectronic device with electrochemical actuation
Mohammad Souri, Sohail Elahi, M. Soltani
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 495-511
Closed Access | Times Cited: 18
Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
Ralf Hass, Juliane von der Ohe, Hendrik Ungefroren
Cancers (2020) Vol. 12, Iss. 12, pp. 3716-3716
Open Access | Times Cited: 109
The adaptive transition of glioblastoma stem cells and its implications on treatments
Zeyu Wang, Hao Zhang, Shengchao Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 93
Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications
Hui Ming, Bowen Li, Li Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188519-188519
Closed Access | Times Cited: 73
A cascaded copper-based nanocatalyst by modulating glutathione and cyclooxygenase-2 for hepatocellular carcinoma therapy
Hailong Tian, Sai Zhao, Edouard C. Nice, et al.
Journal of Colloid and Interface Science (2021) Vol. 607, pp. 1516-1526
Closed Access | Times Cited: 70
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 57
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells
Michał Antoszczak, Sebastian Müller, Tatiana Cañeque, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 26, pp. 11536-11545
Closed Access | Times Cited: 49
The 2022 Report on the Human Proteome from the HUPO Human Proteome Project
Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, et al.
Journal of Proteome Research (2022) Vol. 22, Iss. 4, pp. 1024-1042
Open Access | Times Cited: 47
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
Frank Eckerdt, Leonidas C. Platanias
Cancers (2023) Vol. 15, Iss. 13, pp. 3458-3458
Open Access | Times Cited: 36
Clinical Chemotherapeutic Agent Coordinated Copper‐Based Nanoadjuvants for Efficiently Sensitizing Cancer Chemo‐Immunotherapy by Cuproptosis‐Mediated Mitochondrial Metabolic Reprogramming
Hailong Tian, Jiufei Duan, Bowen Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 51
Open Access | Times Cited: 36
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 32
Resveratrol as sensitizer in colorectal cancer plasticity
Aranka Brockmueller, Anjana Sajeev, Lenka Koklesová, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 55-85
Open Access | Times Cited: 26
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 25
The prevention of multi-drug resistance in cancers through the application of nanotechnology-based targeted delivery systems for combination therapies involving traditional Chinese medicine
Salik Abdullah, Shreya Mukherjee, Shweta Shweta, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100386-100386
Open Access | Times Cited: 13
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Nobendu Mukerjee, Sagnik Nag, Bikramjit Bhattacharya, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 11
Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis
Claudia Tanja Mierke
Biomolecules (2024) Vol. 14, Iss. 2, pp. 184-184
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top